Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen D Mayes

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Arthritis Care & Research|January 15, 2024
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic SclerosisBochra Jandali, Marka Lyons, Julio Charles, et al.
The Journal of Rheumatology|June 18, 2013
Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomesSofia de Achaval, Michael A Kallen, Maureen D Mayes, et al.
The American Journal of Medicine|August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosisShervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis Research & Therapy|March 9, 2017
Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosisColine A Gentil, Hilary S Gammill, Christine T Luu, et al.
Rheumatology (Oxford, England)|January 3, 2018
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosisJohn D Pauling, Gloria Salazar, Hui Lu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 30, 2016
Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristicsErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
Arthritis Research & Therapy|October 16, 2021
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?Victor Farutin, Elma Kurtagic, Joël R Pradines, et al.
Arthritis and Rheumatism|August 9, 2003
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationMaureen D Mayes, James V Lacey, Jennifer Beebe-Dimmer, et al.
Seminars in Arthritis and Rheumatism|June 26, 2022
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral centerBrian H Lam, Shervin Assassi, Julio Charles, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Arthritis Care & Research|January 15, 2024
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic SclerosisBochra Jandali, Marka Lyons, Julio Charles, et al.
The Journal of Rheumatology|June 18, 2013
Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomesSofia de Achaval, Michael A Kallen, Maureen D Mayes, et al.
The American Journal of Medicine|August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosisShervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis Research & Therapy|March 9, 2017
Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosisColine A Gentil, Hilary S Gammill, Christine T Luu, et al.
Rheumatology (Oxford, England)|January 3, 2018
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosisJohn D Pauling, Gloria Salazar, Hui Lu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 30, 2016
Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristicsErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
Arthritis Research & Therapy|October 16, 2021
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?Victor Farutin, Elma Kurtagic, Joël R Pradines, et al.
Arthritis and Rheumatism|August 9, 2003
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationMaureen D Mayes, James V Lacey, Jennifer Beebe-Dimmer, et al.
Seminars in Arthritis and Rheumatism|June 26, 2022
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral centerBrian H Lam, Shervin Assassi, Julio Charles, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Pageof 24